Antibiotics in Necrotizing Soft Tissue Infections.

anti-toxinic antibiotic beta-lactam clindamycin necrotizing soft tissue infections pharmacodynamics pharmacokinetics piperacillin-tazobactam tissue diffusion

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
13 Sep 2021
Historique:
received: 27 08 2021
revised: 08 09 2021
accepted: 10 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

Necrotizing soft tissue infections (NSTIs) are rare life-threatening bacterial infections characterized by an extensive necrosis of skin and subcutaneous tissues. Initial urgent management of NSTIs relies on broad-spectrum antibiotic therapy, rapid surgical debridement of all infected tissues and, when present, treatment of associated organ failures in the intensive care unit. Antibiotic therapy for NSTI patients faces several challenges and should (1) carry broad-spectrum activity against gram-positive and gram-negative pathogens because of frequent polymicrobial infections, considering extended coverage for multidrug resistance in selected cases. In practice, a broad-spectrum beta-lactam antibiotic (e.g., piperacillin-tazobactam) is the mainstay of empirical therapy; (2) decrease toxin production, typically using a clindamycin combination, mainly in proven or suspected group A streptococcus infections; and (3) achieve the best possible tissue diffusion with regards to impaired regional perfusion, tissue necrosis, and pharmacokinetic and pharmacodynamic alterations. The best duration of antibiotic treatment has not been well established and is generally comprised between 7 and 15 days. This article reviews the currently available knowledge regarding antibiotic use in NSTIs.

Identifiants

pubmed: 34572686
pii: antibiotics10091104
doi: 10.3390/antibiotics10091104
pmc: PMC8466904
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Clin Infect Dis. 1998 Jan;26(1):1-10; quiz 11-2
pubmed: 9455502
Int J Antimicrob Agents. 2010 May;35(5):431-8
pubmed: 20219329
Expert Rev Anti Infect Ther. 2017 Jul;15(7):677-688
pubmed: 28571493
World J Emerg Surg. 2018 Dec 14;13:58
pubmed: 30564282
Diagn Microbiol Infect Dis. 2004 Feb;48(2):125-30
pubmed: 14972382
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12353-E12362
pubmed: 30482864
Br J Dermatol. 2020 Jul;183(1):105-113
pubmed: 31610037
Nat Commun. 2019 Aug 26;10(1):3846
pubmed: 31451691
Int J Antimicrob Agents. 2012 Jul;40(1):51-4
pubmed: 22584101
BMJ Case Rep. 2019 Nov 26;12(11):
pubmed: 31776156
Intensive Care Med. 2016 Oct;42(10):1535-1545
pubmed: 26754759
Front Med (Lausanne). 2021 Mar 04;7:609497
pubmed: 33748150
Crit Care. 2021 Apr 12;25(1):139
pubmed: 33845883
Bull Acad Natl Med. 2004;188(3):473-86; discussion 486-90
pubmed: 15584657
Ann Intensive Care. 2021 Jul 2;11(1):102
pubmed: 34213694
Surg Infect (Larchmt). 2015 Oct;16(5):618-25
pubmed: 26115414
Clin Infect Dis. 2021 Jun 25;:
pubmed: 34170310
Lancet Infect Dis. 2018 Jan;18(1):108-120
pubmed: 29102324
Clin Pharmacokinet. 2014 Aug;53(8):695-730
pubmed: 24972859
J Antimicrob Chemother. 1983 Nov;12(5):481-8
pubmed: 6671925
Clin Microbiol Infect. 2020 Jan;26(1):8-17
pubmed: 31284035
Am J Surg. 2007 Dec;194(6):809-12; discussion 812-3
pubmed: 18005776
Clin Infect Dis. 2014 Apr;58(8):1072-83
pubmed: 24429437
PLoS One. 2012;7(4):e35218
pubmed: 22511985
J Infect. 2018 Jan;76(1):38-43
pubmed: 28962969
Pancreatology. 2016 Sep-Oct;16(5):719-25
pubmed: 27267056
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115292
pubmed: 33360809
Nat Rev Microbiol. 2004 Apr;2(4):289-300
pubmed: 15031728
Antimicrob Agents Chemother. 2004 Dec;48(12):4718-24
pubmed: 15561849
Int J Antimicrob Agents. 2001 Oct;18(4):395-8
pubmed: 11691576
Surg Infect (Larchmt). 2005 Winter;6(4):419-26
pubmed: 16433606
Undersea Hyperb Med. 2011 Jan-Feb;38(1):11-6
pubmed: 21384759
BMC Infect Dis. 2015 Feb 19;15:78
pubmed: 25879713
Br J Surg. 1983 Sep;70(9):532-4
pubmed: 6616157
J Antimicrob Chemother. 1997 Aug;40(2):275-7
pubmed: 9301995
BMC Infect Dis. 2012 Dec 12;12:348
pubmed: 23234429
Injury. 2019 Dec;50(12):2203-2214
pubmed: 31591007
Int J Antimicrob Agents. 2018 Mar;51(3):443-449
pubmed: 29180280
N Engl J Med. 2019 Jun 13;380(24):2327-2340
pubmed: 31189036
Crit Care. 2010;14(4):R126
pubmed: 20594297
J Clin Pharm Ther. 2003 Dec;28(6):465-9
pubmed: 14651668
Eur J Clin Microbiol Infect Dis. 2021 May 27;:
pubmed: 34046804
Int J Antimicrob Agents. 2008 Apr;31(4):345-51
pubmed: 18313273
Surg Infect (Larchmt). 2015 Oct;16(5):533-7
pubmed: 26110633
Am J Respir Crit Care Med. 2016 Sep 15;194(6):681-91
pubmed: 26974879
Crit Care. 2011;15(5):R206
pubmed: 21914174
Pediatr Pharmacol (New York). 1983;3(3-4):313-20
pubmed: 6330656
Diagn Microbiol Infect Dis. 2015 Sep;83(1):77-81
pubmed: 26072149
Intensive Care Med. 2020 Sep;46(9):1739-1742
pubmed: 32394067
J Antimicrob Chemother. 2013 Dec;68(12):2852-8
pubmed: 23873647
JCI Insight. 2016 Jul 7;1(10):e87882
pubmed: 27699220
Int J Infect Dis. 2019 Aug;85:127-131
pubmed: 31096056
J Antimicrob Chemother. 2010 Aug;65(8):1771-8
pubmed: 20530507
Am J Med. 1952 Oct;13(4):389-99
pubmed: 12985596
Infect Chemother. 2017 Dec;49(4):301-325
pubmed: 29299899
N Engl J Med. 2005 Apr 7;352(14):1445-53
pubmed: 15814880
Intensive Care Med. 2020 Jun;46(6):1127-1153
pubmed: 32383061
J Antimicrob Chemother. 1996 Aug;38(2):237-43
pubmed: 8877537
Infect Dis Ther. 2014 Dec;3(2):269-79
pubmed: 25410773
Intensive Care Med. 2011 Apr;37(4):632-8
pubmed: 21136037
J Infect Dis. 2017 Jan 15;215(2):269-277
pubmed: 27247345
Clin Infect Dis. 2021 Jan 27;72(2):293-300
pubmed: 31923305
Br J Dermatol. 2019 Sep;181(3):444-445
pubmed: 31353448
Antimicrob Agents Chemother. 2011 Sep;55(9):4170-5
pubmed: 21709078
Curr Opin Infect Dis. 2016 Apr;29(2):153-9
pubmed: 26836376
Int J Antimicrob Agents. 2016 Mar;47(3):247-8
pubmed: 26897754
Br J Dermatol. 2017 Dec;177(6):1575-1582
pubmed: 28452064
J Infect Dis. 1988 Jul;158(1):23-8
pubmed: 3292661
BMC Infect Dis. 2020 Jan 20;20(1):60
pubmed: 31959118
Surg Infect (Larchmt). 2011 Dec;12(6):465-7
pubmed: 22136488
Antimicrob Agents Chemother. 2004 Jan;48(1):63-8
pubmed: 14693519
N Engl J Med. 2017 Dec 7;377(23):2253-2265
pubmed: 29211672
Am J Surg. 2011 Aug;202(2):139-45
pubmed: 21545997
Clin Infect Dis. 2018 Oct 15;67(9):1333-1338
pubmed: 29648630
Asian J Surg. 2017 Jul;40(4):290-294
pubmed: 26774691
Antimicrob Agents Chemother. 1978 Sep;14(3):498-9
pubmed: 708028
Diabet Med. 2001 Mar;18(3):229-34
pubmed: 11318845
Crit Care Med. 2001 Feb;29(2):385-91
pubmed: 11246321
Med Mal Infect. 2016 Jul;46(5):242-68
pubmed: 27112521
Crit Care Med. 2018 Feb;46(2):236-243
pubmed: 29116995
J Antimicrob Chemother. 1993 Apr;31(4):581-4
pubmed: 8514652
Intensive Care Med. 2019 Sep;45(9):1241-1251
pubmed: 31440795
Antimicrob Agents Chemother. 2002 Nov;46(11):3484-9
pubmed: 12384354
J Dtsch Dermatol Ges. 2019 Mar;17(3):345-369
pubmed: 30920735
Nat Biotechnol. 2019 Jul;37(7):783-792
pubmed: 31235920
Crit Care. 2019 Dec 21;23(1):417
pubmed: 31864406
Crit Care Med. 2006 Jun;34(6):1589-96
pubmed: 16625125
J Antimicrob Chemother. 2001 Apr;47(4):421-9
pubmed: 11266414
Cochrane Database Syst Rev. 2018 May 31;5:CD011680
pubmed: 29851032
Ann R Coll Surg Engl. 1992 Jul;74(4):274-6
pubmed: 1416682
J Am Acad Dermatol. 2015 Dec;73(6):1006-12.e8
pubmed: 26412163
J Antimicrob Chemother. 2010 Jun;65(6):1252-7
pubmed: 20375031
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29109162
Clin Infect Dis. 2014 Aug 1;59(3):358-65
pubmed: 24785239
Gut. 1997 Apr;40(4):526-30
pubmed: 9176083
JAMA Dermatol. 2019 Sep 1;155(9):1033-1040
pubmed: 31188407
Intensive Care Med. 2017 Mar;43(3):304-377
pubmed: 28101605
Antimicrob Agents Chemother. 2007 Feb;51(2):461-7
pubmed: 17101685
Antimicrob Agents Chemother. 2007 May;51(5):1725-30
pubmed: 17307978
Antimicrob Agents Chemother. 2021 Jan 20;65(2):
pubmed: 33257446
Antimicrob Agents Chemother. 2006 Apr;50(4):1372-5
pubmed: 16569854
Antimicrob Agents Chemother. 2003 May;47(5):1752-5
pubmed: 12709354
Infection. 2009 Oct;37(5):407-17
pubmed: 19768381
Enferm Infecc Microbiol Clin. 2016 Oct;34(8):477-83
pubmed: 26656792
Antimicrob Agents Chemother. 2003 May;47(5):1771-3
pubmed: 12709358
Antimicrob Agents Chemother. 1994 Apr;38(4):830-6
pubmed: 8031054
Ann Intensive Care. 2019 Oct 24;9(1):123
pubmed: 31650379
World J Emerg Surg. 2020 Jan 8;15:4
pubmed: 31921330
Surg Infect (Larchmt). 2016 Dec;17(6):773-778
pubmed: 27834617
Int J Antimicrob Agents. 2010 Feb;35(2):156-63
pubmed: 20018492
Int J Antimicrob Agents. 2001 Jun;17(6):497-504
pubmed: 11397621
J Antimicrob Chemother. 1982 Sep;10(3):193-6
pubmed: 6292157
Clin Infect Dis. 2014 Jul 15;59(2):e10-52
pubmed: 24973422
J Clin Microbiol. 1995 Sep;33(9):2382-7
pubmed: 7494032
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28893779
Crit Care Med. 2008 May;36(5):1500-6
pubmed: 18434883
Ann Pharmacother. 2021 Jul;55(7):902-913
pubmed: 33135457
Head Neck. 2018 Sep;40(9):2094-2102
pubmed: 29934952
Lancet Infect Dis. 2021 May;21(5):697-710
pubmed: 33333013
World J Surg. 2020 Aug;44(8):2580-2591
pubmed: 32383053
Antibiotics (Basel). 2020 Dec 21;9(12):
pubmed: 33371322
Antimicrob Agents Chemother. 2005 Jan;49(1):461-3
pubmed: 15616337

Auteurs

Tomas Urbina (T)

Médecine Intensive Réanimation, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris (AP-HP), 75571 Paris, France.
Sorbonne Université, Université Pierre-et-Marie Curie, 75001 Paris, France.

Keyvan Razazi (K)

Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), 94010 Créteil, France.
Groupe de Recherche Clinique CARMAS, Faculté de Médecine, Université Paris Est Créteil, 94010 Créteil, France.

Clément Ourghanlian (C)

Service de Pharmacie, Hôpitaux Universitaires Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), 94010 Créteil, France.
Unité Transversale de Traitement des Infections, Département de Prévention, Diagnostic et Traitement des Infections, Hôpitaux Universitaires Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), 94010 Créteil, France.

Paul-Louis Woerther (PL)

Département de Prévention, Diagnostic et Traitement des Infections, Hôpitaux Universitaires Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), 94010 Créteil, France.
Research Group Dynamic, Faculté de Santé de Créteil, Université Paris-Est Créteil Val de Marne (UPEC), 94010 Créteil, France.

Olivier Chosidow (O)

Research Group Dynamic, Faculté de Santé de Créteil, Université Paris-Est Créteil Val de Marne (UPEC), 94010 Créteil, France.
Service de Dermatologie, Hôpitaux Universitaires Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), 94010 Créteil, France.

Raphaël Lepeule (R)

Unité Transversale de Traitement des Infections, Département de Prévention, Diagnostic et Traitement des Infections, Hôpitaux Universitaires Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), 94010 Créteil, France.

Nicolas de Prost (N)

Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris (AP-HP), 94010 Créteil, France.
Groupe de Recherche Clinique CARMAS, Faculté de Médecine, Université Paris Est Créteil, 94010 Créteil, France.

Classifications MeSH